Veeva ePRO simplifies the collection and sharing of patient-reported results in digital clinical trials
BARCELONA, Spain, Oct. 18, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced the availability of Veeva ePRO, a key advancement in digital patient-centric trials. The app makes it easy for patients to complete assessments on a mobile device or web browser and enables real-time data access for sponsors and clinical research sites. As part of a connected platform for clinical trials, study teams can use ePRO to exchange high-quality data across the clinical ecosystem to improve transparency and collaboration.
According to research centers, the main challenges in patient retention include the time required to participate in a trial, repetitive requests for information, and the time spent on data entry.1 Veeva ePRO improves the patient experience by providing an application modern and easy to use to complete the Patient Reported Results (PRO).
The app also helps streamline trial activities for sponsors and research sites. Sponsors can configure studies using survey and instrument libraries and send ePRO and program definitions to research centers. Research centers can then easily assign activities, automatically receive updates, and track patient progress without the need for additional systems or applications.
"Veeva ePRO is built to meet the needs of patients, facilities and sponsors, and is connected for end-to-end execution," said Tim Davis, vice president of strategy, MyVeeva for Patients at Veeva. "We are committed to partnering with customers to deliver modern digital applications that help the life sciences industry move toward patient-centric digital trials."
Veeva ePRO is part of the Veeva Vault Clinical Suite, the industry's first cloud platform that unifies clinical data management and operations. The Vault Clinical Suite includes Vault EDC, Veeva RTSM, Veeva ePRO, Veeva CDB, Vault eTMF, Vault CTMS, Veeva Site Connect, Vault Payments, Vault Study Start-up, and Vault Study Training. Learn more about Veeva ePRO at veeva.com/eu/ePRO.
Additional Information
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems Follow @veeva_eu on Twitter: twitter.com/veeva_eu
About Veeva Systems
Veeva is the world leader in cloud software for the life sciences industry. Committed to innovation, product excellence and customer success, Veeva serves more than 1,000 customers, from the world's largest pharmaceutical companies to emerging biotech companies. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit the website veeva.com/eu.
Veeva Forward Looking Statements
This release contains forward-looking statements about Veeva's products and services and the expected results or benefits from the use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update any such statements. There are numerous risks that may adversely affect our results, including the risks and uncertainties set forth in our filing on Form 10-Q for the period ended July 31, 2022, which you can find here (on pages 39-40). a summary of risks that may affect our business), and in our subsequent filings with the SEC, which you can access at sec.gov.
1 Informe de investigación de SCRS, Impact Assessment of eClinical Technologies and Industry Initiatives on Sites, 2019
Logo - https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg
View original content: https://www.prnewswire.com/news-releases/veeva-presenta-la-nueva-aplicacion-epro-para-un-acceso-mas-rapido-a-los-datos-de-los-pacientes-301652779.html
